Clinical Trials Directory

Trials / Conditions / Growth Disorder

Growth Disorder

14 registered clinical trials studyying Growth Disorder — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingEvaluation of Children With Endocrine and Metabolic-Related Conditions
NCT02769975
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)—
CompletedValidation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of
NCT02580032
Novo Nordisk A/S—
CompletedStudy of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation
NCT02428296
National Human Genome Research Institute (NHGRI)Phase 2
TerminatedGenetic Causes of Growth Disorders
NCT02311322
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)—
CompletedA Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Heal
NCT01943084
Novo Nordisk A/SPhase 1
WithdrawnBioequivalence of Two Products (Norditropin® Versus Nutropin AQ®) in Healthy Adult Volunteers
NCT01512095
Novo Nordisk A/SPhase 1
CompletedEfficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short S
NCT01778023
Novo Nordisk A/SPhase 3
CompletedBioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers
NCT01401244
Novo Nordisk A/SPhase 1
CompletedFrench National Registry of Children Born Small for Gestational Age Treated With Somatropin
NCT01578135
Novo Nordisk A/S—
CompletedTreatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height
NCT00174421
PfizerPhase 3
CompletedAmendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short Stature
NCT00191074
Eli Lilly and CompanyPhase 3
CompletedSafety and Efficacy of Long-term Somatropin Treatment in Children
NCT01543867
Novo Nordisk A/S—
CompletedEffect of Growth Hormone in Children With Growth Hormone Deficiency
NCT00262249
Novo Nordisk A/SPhase 3
CompletedStudy of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature
NCT00001190
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Phase 2